← Evidence map

ArticleCell research2022

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.

Jingwen Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

62 papers cite itlatest 60 shown

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34815511